Tag: Sleep Apnea
Study: Retatrutide decreases AHI in adults with sleep apnea
October 22, 2026HME News Staff
BOSTON – Retatrutide, an investigational triple agonist of glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1 and glucagon receptors, may be useful for treating obstructive sleep apnea (OSA), according to a study published in the New England Journal of Medicine. “In adults with OSA and obesity or overweight with or without Type 2 diabetes, retatrutide resulted in significantly greater decreases in the AHI than placebo,” researchers concluded. A total of 243 participants...
HealthTap launches program to support DME suppliers across sleep therapy journey
October 12, 2026HME News Staff
SUNNYVALE, Calif. – HealthTap, a nationwide virtual primary care physician practice, has announced a comprehensive clinical offering for sleep and respiratory durable medical equipment (DME) suppliers. The program connects patients with primary care physicians on HealthTap to support visits across the PAP supply process, from initial evaluation and therapy orders through compliance, resupply and device replacement. "Sleep DME teams work hard to keep patients on therapy, but too often progress...
AADSM qualifies 2,500 dentists for OAT
September 10, 2026HME News Staff
LISLE, Ill. – The American Academy of Dental Sleep Medicine (AADSM) has announced that 2,500 dentists across the country have achieved AADSM Qualified Dentist status, strengthening patient access to oral appliance therapy (OAT) for obstructive sleep apnea (OSA). "Reaching 2,500 AADSM Qualified Dentists is an important milestone for patients who need convenient access to high-quality care close to home," said AADSM President Dr. Paul Jacobs. "Obstructive sleep apnea is a serious...
In brief: CPAP’s adherence assumption, CGM’s benefits, Shaq’s sleep apnea
June 12, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
New research questions Medicare’s 90-day rule for CPAP adherence
June 11, 2026HME News Staff
ORLANDO, Fla. – Many insurers stop covering continuous positive airway pressure (CPAP) devices if patients don’t use them regularly in the first 90 days. But new research presented at the ATS 2026 International Conference shows that many patients who initially struggle to meet these early-use thresholds do go on to use and benefit from CPAP therapy.
The findings challenge long-held assumptions that poor early use predicts long-term CPAP use, said first author Dennis Hwang, MD, a sleep...
Sweet spot of resupply: Intersection of good data, great team
June 10, 2026Theresa Flaherty
WATERLOO, Iowa – Providers need to measure the success of their resupply program with key metrics, VGM Fulfillment’s Mike DiMarco told Heartland Conference attendees this week.
“Having incomplete or fragmented data makes it difficult to leverage and act on,” said DiMarco, vice president of operations excellence at VGM Fulfillment. “You want to leverage your data and routines to be proactive vs. reactive.”
DiMarco spoke during a panel session titled...
Dreem Health wants to build a better sleep journey
May 29, 2026Theresa Flaherty
NEW YORK – Dreem Health has joined Amazon’s Health Benefits Connector service, a move the virtual sleep clinic says will help capture the growing momentum of patients actively seeking diagnosis and treatment.
Amazon’s Health Benefits Connector service offers health plan eligibility checks for online users searching for products related to sleep and sleep health.
“If they are eligible, they are guided through a dedicated enrollment flow and then proceed to potentially...
Sunrise Group receives FDA clearance for home sleep test
May 20, 2026HME News Staff
NEW YORK – Sunrise Group has received clearance from the U.S. Food and Drug Administration (FDA) for its Sunrise Air home sleep test. This clearance marks a major step forward in Sunrise’s mission to expand access to high-quality sleep care by providing a best-in-class, convenient, and clinically robust sleep apnea diagnostic solution that can be completed entirely at home, the company says. “Sunrise has already set a new benchmark for home sleep testing through its high level of...
In brief: CMS ups MA payments, Sleep Cycle sees interest, Soleo Health expands
April 10, 2026HME News Staff
WASHINGTON – The Centers for Medicare & Medicaid Services (CMS) has set a net average increase of 2.48% for Medicare Advantage plans in calendar year 2027, representing more than $13 billion in additional payments.
Earlier this year, CMS had proposed a net average increase of 0.09%, representing $700 million in additional payments.
CMS touts improved payment accuracy
In a new rate announcement, the agency says this expected increase includes consideration of the various elements that...
Sleep Cycle reports early interest ahead of launch
April 8, 2026HME News Staff
GOTHENBURG, Sweden – More than 150,000 people have registered interest in an upcoming sleep apnea risk detection solution from Sleep Cycle ahead of its commercial launch. The AI-powered sleep tech company says strong early demand underscores a significant need within sleep health and supports is strategic expansion into medical technology and scalable digital health solutions. “Sleep apnea remains significantly underdiagnosed, despite its serious impact on long-term health and quality...